Assignee
HERON THERAPEUTICS INC
US·34 granted patents·23 pending applications·230 citations·filing 2013–2025
Top patents by PatentIndex Score
57 records- 0199US11173118B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2020·Granted Nov 16, 2021·13 cites·18 claims
- 0298US11878074B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·7 cites·14 claims
- 0398US11744800B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·7 cites·30 claims
- 0498US10953018B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2019·Granted Mar 23, 2021·12 cites·18 claims
- 0598US10624850B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·12 cites·16 claims
- 0698US9974742B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2016·Granted May 22, 2018·18 cites·23 claims
- 0797US9974793B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·18 cites·22 claims
- 0897US9808465B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·23 cites·15 claims
- 0997US9561229B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2016·Granted Feb 7, 2017·22 cites·21 claims
- 1096US10500208B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·15 cites·17 claims
- 1196US9974794B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·14 cites·21 claims
- 1296US9801945B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·9 cites·30 claims
- 1396US9694079B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Jul 4, 2017·19 cites·14 claims
- 1495US11413350B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2020·Granted Aug 16, 2022·3 cites·110 claims
- 1592US10632199B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·3 cites·20 claims
- 1692US10213510B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2015·Granted Feb 26, 2019·10 cites·19 claims
- 1791US12290520B2Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2024·Granted May 6, 2025·0 cites·24 claims
- 1891US10098957B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·3 cites·24 claims
- 1987US12115255B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2024·Granted Oct 15, 2024·0 cites·30 claims
- 2087US11253504B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2019·Granted Feb 22, 2022·1 cites·15 claims
- 2186US12115254B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2024·Granted Oct 15, 2024·0 cites·30 claims
- 2285US11083730B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Aug 10, 2021·2 cites·54 claims
- 2385US11083797B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Aug 10, 2021·1 cites·20 claims
- 2485US10898575B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Jan 26, 2021·3 cites·79 claims
- 2584US2025228867A1Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2684US2024238197A1Methods of use of emulsion formulations of an nk-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2784US2025161458A1Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2883US10398686B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·2 cites·10 claims
- 2982US9446036B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Sep 20, 2016·5 cites·14 claims
- 3081US12318376B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2022·Granted Jun 3, 2025·0 cites·19 claims
- 3181US10357570B2Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronHERON THERAPEUTICS INC·Filed 2018·Granted Jul 23, 2019·1 cites·17 claims
- 3280US9913909B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2016·Granted Mar 13, 2018·2 cites·15 claims
- 3380US9592227B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Mar 14, 2017·3 cites·25 claims
- 3478US2021252156A1Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3577US10980886B2Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2015·Granted Apr 20, 2021·1 cites·7 claims
- 3677US2021186981A1Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3776US2020405866A1Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronHERON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3875US2021330796A1Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3974US11844837B2Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2021·Granted Dec 19, 2023·0 cites·9 claims
- 4071US9744163B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Aug 29, 2017·1 cites·21 claims
- 4171US2025387487A1Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4267US2021338820A1Pharmaceutical composition comprising antiemetic compounds and polyorthoesterHERON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4367US2014371187A1Semi-solid delivery vehicle and pharmaceutical compositionsHERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4466US9913910B2Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronHERON THERAPEUTICS INC·Filed 2016·Granted Mar 13, 2018·0 cites·18 claims
- 4566US2015320866A1Pharmaceutical composition comprising antiemetic compounds and polyorthoesterHERON THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4664US2024307266A1Vial access needle deviceHERON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4763US2020061035A1Long-acting polymeric delivery systems comprising olanzapine and a 5-ht3 receptor antagonistHERON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4862US2017232107A1Pharmaceutical composition comprising antiemetic compounds and polyorthoesterHERON THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4960US2014323517A1Compositions and methods for injection of a biodegradable polymer-based delivery systemHERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 5056US2017340740A1Long-acting polymeric delivery systems comprising olanzapine and a 5-ht3 receptor antagonistHERON THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →